mDASHNa-CC APP to Support a Healthy Diet and Hypertension Control for Chinese Canadian Seniors
Design, Usability Testing, and Feasibility Testing of a Smartphone App (mDASHNa-CC) to Support Healthy Diet and Hypertension Control for Chinese Canadian Seniors
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The aim of this proposed study is to translate the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadian (DASHNa-CC), a classroom-based antihypertensive dietary educational intervention, to an innovative smartphone app (mDASHNa-CC) to enable Chinese Canadian seniors' access to this antihypertensive dietary intervention anytime, regardless of where they are.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1 hypertension
Started Jan 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2019
CompletedFirst Posted
Study publicly available on registry
June 18, 2019
CompletedStudy Start
First participant enrolled
January 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJune 18, 2019
June 1, 2019
11 months
June 8, 2019
June 15, 2019
Conditions
Outcome Measures
Primary Outcomes (5)
change of systolic Blood Pressure from baseline to eight weeks after randomization
Systolic blood pressures will be measured by the home blood pressure monitor, Omron BP785, whose validity and reliability have been tested
eight weeks after randomization
change of diastolic Blood Pressure from baseline to eight weeks after randomization
diastolic blood pressures will be measured by the home blood pressure monitor, Omron BP785, whose validity and reliability have been tested
eight weeks after randomization
change of body weight from baseline to eight weeks after randomization
Weight will be measured by an electronic body weight scale (Rubbermaid® Digital Utility Scale, Model number H-479, Capacity/Accuracy 400 lbs \* 0.5 lb)
eight weeks after randomization
change of waist circumference from baseline to eight weeks after randomization
Waist circumference will be measured by measurement tape following proper technique
eight weeks after randomization
change of Health-related Quality of Life from baseline to eight weeks after randomization
Health-related quality of life will be measured by Medical Outcomes Study 36-Item Short Form version two. The SF-36v2 required ten minutes to complete and consisted of 36 items and eight domains, which could be grouped into physical and mental component summaries. All domains were scored on a scale ranging from 0 to 100, wherein 0 represented the worst overall health status and 100 the best health status.
eight weeks after randomization
Study Arms (2)
Control: Usual Care
NO INTERVENTIONAll participants will (a) receive a general hypertension health education booklet from the Heart and Stroke Foundation of Ontario;(b) be encouraged to see their family physicians or primary health care providers regarding their blood pressure status; those who do not have a primary health care provider will be referred to a walk-in clinic or a community health centre; and (c) have access to family physicians, tele-health, emergency care, hospital and other health care facilities in the Greater Toronto Area as required.
Intervention: mDASHNa-CC app use
ACTIVE COMPARATORIn addition to usual care, those participants randomized to the intervention group will be offered use of the app.Then, they will load the app in their smartphones and be requested to review educational contents, conduct dietary self-assessment, and monitor blood pressure for 8 weeks.By the end of eight weeks post randomization, seniors will be prompted by phone using an audible alert to complete the app Evaluation Questionnaire on the smartphone, which ascertains likes and dislikes with the app.
Interventions
The functions of the app will include: (a) antihypertensive dietary education; (b) dietary self-assessment; (c) automatic feedback according to dietary self-assessment; (d) blood pressure monitoring; and (e) automatic feedback according to blood pressure data.
Eligibility Criteria
You may qualify if:
- have a systolic blood pressure higher than 140 mmHg, or a diastolic blood pressure higher than 90mmHg, or are on antihypertensive medications, based on pre-intervention baseline assessment
- are able to understand (listen) and speak in Mandarin or Cantonese, read and write in Chinese
- have access to a smartphone
You may not qualify if:
- have special dietary requirements
- are a household member of another mDASHNa-CC participant
- plan to leave the area prior to the anticipated end of study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Zou P, Stinson J, Parry M, Dennis CL, Yang Y, Lu Z. A Smartphone App (mDASHNa-CC) to Support Healthy Diet and Hypertension Control for Chinese Canadian Seniors: Protocol for Design, Usability and Feasibility Testing. JMIR Res Protoc. 2020 Apr 2;9(4):e15545. doi: 10.2196/15545.
PMID: 32238343DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 8, 2019
First Posted
June 18, 2019
Study Start
January 10, 2020
Primary Completion
December 1, 2020
Study Completion
June 30, 2021
Last Updated
June 18, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share